This Investor Sold Million: Why Biotech Shares Stay Bullish
A prominent investor dumped a multi‑million stake in a biotech stock that’s up double digits. This article explains w...
Shifting funds with limited resources requires thoughtful prioritization. This intro provides practical tips to optimize your remaining dollars.
25,048 articlesA prominent investor dumped a multi‑million stake in a biotech stock that’s up double digits. This article explains w...
SSR Mining's move to sell a large stake in a key asset sent its stock higher in a single session. This article breaks...
The Supreme Court's tariff ruling reshapes costs, consumer prices, and corporate margins. This guide breaks down the ...
The May 21 2026 finale of The Late Show with Stephen Colbert has sparked a nationwide debate about monoculture and AI...
Gold’s flagship ETF saw a record-size outflow as crypto-linked funds posted weekly gains. The week ended with mixed s...
A major investment advisor just boosted its stake in the Invesco BulletShares 2027 Corporate Bond ETF by about $76 mi...
As volatility in Bitcoin keeps traders on edge, JPMorgan analysts argue that cash may be the stabilizer behind a bitc...
Choosing between a large-cap growth ETF like VONG and a small-cap growth ETF like SLYG can shape your risk and return...
Roth IRAs offer tax-free growth, but only if you follow the rules. This guide uncovers the landmines that can turn yo...
When choosing biotech ETFs, investors face a trade-off between concentration and breadth. This article compares FBT a...
Two popular ETFs aim at different corners of banking: a broad financials tilt versus a focused regional-banks approac...
As the market keeps rates elevated, three dividend ETFs with over 6% yields offer straightforward income without upsi...